Unexplained weight loss (UWL), defined as a loss of 5% or more of total body weight within a six to twelve month period without an apparent cause, poses a diagnostic challenge for clinicians. It may be an early sign of a serious underlying condition requiring prompt identification and treatment.
UWL can be attributed to a myriad of causes ranging from malignancies, endocrine disorders, gastrointestinal diseases, to psychiatric illnesses. However, in approximately 15-25% of cases, the cause remains elusive despite extensive evaluation. This necessitates a comprehensive, systematic approach to effectively manage these patients.
A thorough history and physical examination are the cornerstones of the diagnostic approach. They can provide valuable clues about potential etiologies. Laboratory testing should be guided by the clinical suspicion. Empirical trials of treatment may be considered if initial investigations are non-revealing.
Imaging studies have a pivotal role in the evaluation of UWL. They can detect occult malignancies, chronic infections, or other systemic diseases. The choice of imaging modality should be individualized based on the patient's history and physical findings.
Collaboration between various specialties is crucial in managing patients with UWL. A multidisciplinary approach can expedite the diagnostic process, improve patient care, and potentially reduce healthcare costs.
Unexplained weight loss is a complex clinical problem that requires a comprehensive and systematic approach. A thorough history, physical examination, and judicious use of laboratory and imaging studies are essential. Collaboration among various specialties can optimize patient outcomes. While the cause may remain elusive in some cases, a meticulous approach can help in the early detection and management of serious underlying conditions.
1.
A US health panel advises starting mammograms at age 40 rather than 50.
2.
TULSA Is Effective in Long-Term Prostate Cancer Control.
3.
J. Craig Venter, Who Won the Race to Sequence the Human Genome, Dies at 79
4.
In Sickle Cell Disease, Lovo-Cel is "Life-Changing, Transformative.".
5.
How Social Determinants of Health Are Linked to Outcomes in Multiple Myeloma
1.
Molecular Matching for Individualized Blood-Disorder Therapy
2.
Everything You Need To Know About Melanoma Choroid: Causes, Symptoms, and Treatment
3.
Drug Safety Surveillance of Long-Term Medication Effects in Cancer Survivorship
4.
HPV-Related Cervical Cancer: Advances in Screening, Preventiofn & Treatment
5.
Early Diagnosis of Lung Cancer Through Emerging Biomarkers
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Current Scenario of Cancer- The Incidence of Cancer in Men
2.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
3.
L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients
4.
Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL
5.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation